Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.

Shmeylan Al HarbiRaed KensaraOhoud AljuhaniGhazwa B KorayemAli F AltebainawiAbdullah Al HarthiRamesh VishwakarmaAlaa M AlenaziAbdulmajed AlmutairiOmar A AlshayaSultan AlraddadiTareq Al SulaimanLatifah AldakkanReem MahboobKholoud AlaamerAbdulrahman AlissaAwatif HafizNada AldhayyanSara AlthewaibiFarhan AleneziNadeen Y AlkhotaniSara A AlghamdiAbeer A AlenaziKhalid Al Sulaiman

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

The use of statin therapy during ICU stay was not associated with thrombosis reduction in critically ill patients with COVID-19; however, it has been associated with survival benefits.

Keyphrases

pulmonary embolism
cardiovascular disease
intensive care unit
coronary artery disease
mechanical ventilation
cross sectional
free survival
double blind
extracorporeal membrane oxygenation